Serum hepcidin as a diagnostic test of iron deficiency in premenopausal female blood donors

Haematologica

Volumn 96, Issue 8, 2011, Pages 1099-1105

  Pasricha, Sant Rayn ^a,b   McQuilten, Zoe ^a   Westerman, Mark ^c   Keller, Anthony ^a   Nemeth, Elizabeta ^c,d   Ganz, Tomas ^c,d   Wood, Erica ^a,b  

^a AUSTRALIAN RED CROSS BLOOD SERVICE   (Australia)

^b ROYAL MELBOURNE HOSPITAL   (Australia)

^c Intrinsic LifeSciences LLC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Blood donors; Diagnostic test; Iron deficiency; Iron status; Premenopausal females; Serum hepcidin

Indexed keywords

C REACTIVE PROTEIN; FERRITIN; HEPCIDIN; TRANSFERRIN RECEPTOR;

ADULT; ARTICLE; BLOOD DONOR; DIAGNOSTIC VALUE; FEMALE; FERRITIN BLOOD LEVEL; HEPCIDIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; PREMENOPAUSE; PROTEIN BLOOD LEVEL; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIMICROBIAL CATIONIC PEPTIDES; BLOOD CHEMICAL ANALYSIS; BLOOD DONORS; DEFICIENCY DISEASES; FEMALE; HUMANS; IRON; PREMENOPAUSE; REFERENCE VALUES; SENSITIVITY AND SPECIFICITY;

EID: 79961085126     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2010.037960     Document Type: Article

References (44)

1. Benoist B, McLean E, Egli I, Cogswell M. Worldwide prevalence of anaemia 1993-2005. Geneva: World Health Organization, 2008.
2. WHO/UNICEF/UNU. Iron Deficiency Anaemia: Assessment, Prevention, and Control. A guide for programme managers. Geneva: World Health Organization; 2001.
3. Ganz T. Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation. Blood. 2003;102(3):783-8.
4. Kemna EH, Tjalsma H, Willems HL, Swinkels DW. Hepcidin: from discovery to differential diagnosis. Haematologica. 2008;93(1):90-7.
5. Kroot JJ, Kemna EH, Bansal SS, Busbridge M, Campostrini N, Girelli D, et al. Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization. Haematologica. 2009;94(12):1748-52.
6. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292-7.
7. Koliaraki V, Marinou M, Vassilakopoulos TP, Vavourakis E, Tsochatzis E, Pangalis GA, et al. A novel immunological assay for hepcidin quantification in human serum. PLoS One. 2009;4(2):e4581.
8. Swinkels DW, Wetzels JF. Hepcidin: a new tool in the management of anaemia in patients with chronic kidney disease? Nephrol Dial Transplant. 2008;23(8):2450-3.
9. Malyszko J, Malyszko JS, Mysliwiec M. Serum prohepcidin and hepcidin in hemodialyzed patients undergoing iron therapy. Kidney Blood Press Res. 2009; 32(4):235-8.
10. Nemeth E. Targeting the hepcidin-ferroportin axis in the diagnosis and treatment of anemias. Adv Hematol. 2010; 2010: 750643.
11. Brugnara C. An immunoassay for human serum hepcidin at last: Ganz klar? Blood. 2008;112(10):3922-3.
12. Badami KG, Taylor K. Iron status and riskprofiling for deficiency in New Zealand blood donors. NZ Med J. 2008;121(1274): 50-60.
13. Boulton F. Evidence-based criteria for the care and selection of blood donors, with some comments on the relationship to blood supply, and emphasis on the management of donation-induced iron depletion. Transfus Med. 2008;18(1):13-27.
14. Guidelines for the selection of blood donors: Australian Red Cross Blood Service; 2010.
15. Kroot JJ, Hendriks JC, Laarakkers CM, Klaver SM, Kemna EH, Tjalsma H, et al. (Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies. Anal Biochem. 2009; 389(2):124-9.
16. Ganz T, Olbina G, Girelli D, Nemeth E, Westerman M. Immunoassay for human serum hepcidin. Blood. 2008;112(10):4292-7.
17. Young MF, Glahn RP, Ariza-Nieto M, Inglis J, Olbina G, Westerman M, et al. Serum hepcidin is significantly associated with iron absorption from food and supplemental sources in healthy young women. Am J Clin Nutr. 2009;89(2):533-8.
18. Girelli D, Trombini P, Busti F, Campostrini N, Sandri M, Pelucchi S, et al. A time course of hepcidin response to iron challenge in HFE and TfR2 Haemochromatosis patients. Haematologica. 2010 Dec 22.
19. Irwig L, Glasziou PP, Berry G, Chock C, Mock P, Simpson JM. Efficient study designs to assess the accuracy of screening tests. Am J Epidemiol. 1994;140(8):759-69.
20. Kirkwood BR, Sterne JA. Essential Medical Statistics. 2nd ed. Oxford: Blackwell Science, 2003.
21. Thomas L, Thomas C, Lehmann P, Roeddiger R, Brugnara C. Iron Deficiency, Erythropoietic Status in Anemia, rHuEPO Therapy: New Diagnostic Approaches - The "Thomas-Plot". Mannheim: Roche Diagnostics GmbH, 2005.
22. Suominen P, Punnonen K, Rajamaki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood. 1998;92(8):2934-9.
23. Thomas C, Thomas L. Biochemical markers and hematologic indices in the diagnosis of functional iron deficiency. Clin Chem. 2002;48(7):1066-76.
24. Fluss R, Faraggi D, Reiser B. Estimation of the Youden Index and its associated cutoff point. Biom J. 2005;47(4):458-72.
25. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44(3):837-45.
26. Fan J, Upadhye S, Worster A. Understanding receiver operating characteristic (ROC) curves. CJEM. 2006;8(1):19-20.
27. Lin XM, Zhang J, Zou ZY, Long Z, Tian W. Evaluation of serum transferrin receptor for iron deficiency in women of child-bearing age. Br J Nutr. 2008;100(5):1104-8.
28. Luo D, Chen Y, Wu W, Zhang F, Xu J, Cui W, et al. Reticulocyte hemoglobin content in the diagnosis of iron deficiency in Chinese pre-menopausal women. Chin Med J (Engl). 2007;120(11):1010-2.
29. Ullrich C, Wu A, Armsby C, Rieber S, Wingerter S, Brugnara C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. JAMA. 2005;294(8):924-30.
30. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39(4):561-77.
31. Remaley AT, Sampson ML, DeLeo JM, Remaley NA, Farsi BD, Zweig MH. Pre - valence-value-accuracy plots: a new method for comparing diagnostic tests based on misclassification costs. Clin Chem. 1999;45(7):934-41.
32. Rockey DC, Cello JP. Evaluation of the gastrointestinal tract in patients with iron-deficiency anemia. N Engl J Med. 1993;329(23): 1691-5.
33. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108(12):3730-5.
34. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, et al. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science. 2004;306(5704):2090-3.
35. Delaby C, Pilard N, Goncalves AS, Beaumont C, Canonne-Hergaux F. Presence of the iron exporter ferroportin at the plasma membrane of macrophages is enhanced by iron loading and down-regulated by hepcidin. Blood. 2005;106(12):3979-84.
36. Brittenham GM, Klein HG, Kushner JP, Ajioka RS. Preserving the national blood supply. Hematology Am Soc Hematol Educ Program. 2001:422-32.
37. Calis JC, Phiri KS, Faragher EB, Brabin BJ, Bates I, Cuevas LE, et al. Severe anemia in Malawian children. New Engl J Med. 2008;358(9):888-99.
38. Tielsch JM, Khatry SK, Stoltzfus RJ, Katz J, LeClerq SC, Adhikari R, et al. Effect of routine prophylactic supplementation with iron and folic acid on preschool child mortality in southern Nepal: community-based, cluster-randomised, placebo-controlled trial. Lancet. 2006;367(9505):144-52.
39. Malyszko J, Mysliwiec M. Hepcidin in anemia and inflammation in chronic kidney disease. Kidney Blood Press Res. 2007;30 (1):15-30.
40. Cheng PP, Jiao XY, Wang XH, Lin JH, Cai YM. Hepcidin expression in anemia of chronic disease and concomitant iron-deficiency anemia. Clin Exp Med. 2001;11(1): 33-42.
41. Lasocki S, Baron G, Driss F, Westerman M, Puy H, Boutron I, et al. Diagnostic accuracy of serum hepcidin for iron deficiency in critically ill patients with anemia. Intensive Care Med. 2010;36(6):1044-8.
42. Thomas C, Kobold U, Balan S, Roeddiger R, Thomas L. Serum hepcidin-25 may replace the ferritin index in the Thomas plot in assessing iron status in anemic patients. Int J Lab Hematol. 2011;32(2):187-93.
43. Wrighting DM, Andrews NC. Iron homeostasis and erythropoiesis. Curr Top Dev Biol. 2008;82:141-67.
44. Punnonen K, Irjala K, Rajamaki A. Serum transferrin receptor and its ratio to serum ferritin in the diagnosis of iron deficiency. Blood. 1997;89(3):1052-7.